Olufemi, D (2020). Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings). Afribary.com: Retrieved March 08, 2021, from https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020
Dada, Olufemi. "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary.com. Afribary.com, 02 Jul. 2020, https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020 . Accessed 08 Mar. 2021.
Dada, Olufemi. "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)". Afribary.com, Afribary.com, 02 Jul. 2020. Web. 08 Mar. 2021. < https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020 >.
Dada, Olufemi. "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary.com (2020). Accessed March 08, 2021. https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020